Company Plumbline Life Sciences, Inc.

Equities

A222670

KR7222670002

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6,040 KRW -0.33% Intraday chart for Plumbline Life Sciences, Inc. +0.83% 0.00%

Business Summary

Plumbline Life Sciences, Inc. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of bio pharmaceuticals for animals using gene therapy. The Company provides small animal personalized medicines, infectious vaccines, growth hormone releasing hormone (GHRH), telomerase reverse transcriptase (TERT) and others. The Company’s products are mainly used for pigs, cats, dogs, cows, horses and other animals.

Managers

Managers TitleAgeSince
Chief Executive Officer 53 13-12-31
Comptroller/Controller/Auditor 74 -
Comptroller/Controller/Auditor 45 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 -
Chief Executive Officer 53 13-12-31
Director/Board Member 52 17-03-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 253,600 0 0 48.65 %
Stock B 0 62,000 0 0
Stock C 0 100,000 0 0
Stock D 1 3,039,890 1,478,897 ( 48.65 %) 92,134 ( 3.031 %)

Company contact information

Plumbline Life Sciences, Inc.

18 Seocho-daero 34-gil Seocho-gu

06661, Seoul

+

http://www.plumblinels.com
address Plumbline Life Sciences, Inc.(A222670)
  1. Stock Market
  2. Equities
  3. A222670 Stock
  4. Company Plumbline Life Sciences, Inc.